Printer Friendly
The Free Library
14,581,301 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Nisshin Science Confirms that Renacare Carnitine Jelly Improves Anemia Associated with Diabetic Nephropathy.


Tokyo, Japan, June 15, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - Nisshin OillliO has announced the results of its latest research on Renacare Carnitine carnitine /car·ni·tine/ (kahr´ni-ten) a betaine derivative involved in the transport of fatty acids into mitochondria, where they are metabolized.

car·ni·tine
n.
 Jelly, a health food for kidney disease Kidney Disease Definition

Kidney disease is a general term for any damage that reduces the functioning of the kidney. Kidney disease is also called renal disease.
 patients developed by Nisshin Science.

In collaboration with its group company Nisshin Science and the Public

Central Hospital of Matto Ishikawa, Nisshin OilliO tried to elucidate how an intake of Renacare jelly improves the conditions of patients with diabetic nephropathy diabetic nephropathy (nfro´p .

The results indicate that the intake can potentially improve anemia in diabetic nephropathy patients.

Details of the research will be presented at the 51st Congress of the Japanese Society for Dialysis Therapy to be held in Yokohama on June 23.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Jun 16, 2006
Words:116
Previous Article:Medinet to Participate in Establishment of Tokyo Bay Medical Frontier.
Next Article:Ako Kasei Confirms that High Mineral Water Helps Suppress Helicobacter Pylori.



Related Articles
ACE inhibitor protects diabetics' kidneys. (angiotensin-converting-enzyme; captopril)
Chronic complications of diabetes. (Featured CME Topic: Diabetes Mellitus).
End-stage renal disease in people with type 2 diabetes: systemic manifestations and exercise implications.(Update)
Proteinuria and microalbuminuria in adults: significance, evaluation, and treatment.(CME Topic)
Sankyo Announces Completion of Subject Registration for ORIENT Clinical Trial.
Improving antihypertensive therapy in patients with diabetic nephropathy.(CME Topic)
Banyu Pharmaceutical Obtains Additional Approval for NU-LOTAN Tablet.
Nisshin Pharma Confirms that Combination of CoQ10 and Carnitine Helps Reduce Body Fat.
Nisshin OilliO Introduces Two New Foods for Kidney Disease Patients.
Astellas Pharma, Nippon Boehringer Ingelheim Seek Additional Approval for Micardis.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles